NewsNestle to acquire remaining share of peanut allergy drug maker Aimmune for $2BadminSeptember 1, 2020 by adminSeptember 1, 2020012A company best known for making food products is acquiring the remainder of a biotech firm that won Food and Drug Administration approval for a...
